Treatment
Treatment clinical trials
We’re tracking 8,585 recruiting studies that include Treatment, each written for real people, not researchers, below.
Recruiting studies
- NCT05626426Recruiting
Electrical stimulation for optic nerve damage from glaucoma
This trial studies whether electrical stimulation can help improve vision in people with glaucoma-related optic nerve damage. You may qualify if your visual field test shows moderate to severe loss and your eye pressure is stable.
Palo Alto, CaliforniaAges 18 years+ - NCT05632913Recruiting
Radiation seeds trial for recurring lung cancer in the chest
This trial tests a treatment that places tiny radiation “seeds” inside/near the chest tumor to treat recurrent lung cancer. It may help people whose cancer has come back and can be safely reached by the radiation device.
JerusalemAges 18 years+ - NCT05633615RecruitingPhase 2
Testing new drug options after CAR T for aggressive lymphoma
This Phase 2 study tests whether adding or switching drug treatments after CAR T-cell therapy can improve outcomes for people with certain aggressive lymphomas that have come back or did not respond. It mainly looks at who remains disease-stable/partly improved after CAR T and what treatment approach works best next.
Tucson, ArizonaAges 18 years+ - NCT05634057Recruiting
Treating sepsis with a medication plus blood thinner
This trial studies whether combining anisodamine (a medicine for certain gut/smooth-muscle effects) with a low-molecular-weight blood thinner helps treat sepsis. It may be aimed at improving outcomes compared with standard care, but eligibility depends on safety factors like bleeding risk and organ function.
Beijing, ChinaAges 18–110 - NCT05635669Recruiting
Acupuncture for mild to moderate stress urine leaks
This trial studies whether an “optimized” acupuncture treatment can reduce urine leakage caused by stress, like coughing or laughing. It is mainly for adults with mild to moderate stress urinary incontinence who are medically able to receive acupuncture.
ShanghaiAges 40–75 - NCT05638594RecruitingPhase 2
Neoadjuvant drug study for hormone- and HER2-positive breast cancer
This trial compares two combination treatment plans given before breast surgery (neoadjuvant therapy) for ER-positive and HER2-positive stage II–III breast cancer. It aims to see which plan works better to shrink the tumor and improve outcomes.
Shenyang, LiaoningAges 18–75 - NCT05639933RecruitingPhase 2
Topical cream for EGFR inhibitor skin rash in cancer patients
This Phase 2 study tests a topical cream (HT-001) to treat skin rashes caused by EGFR inhibitors. It aims to see whether the cream is safe and can reduce rash symptoms and discomfort.
Irvine, CaliforniaAges 18 years+ - NCT05641623RecruitingPhase 2
Study drug for depression that didn’t improve on common antidepressants
This Phase 2 trial tests OSU6162 added to an SSRI or SNRI in people whose major depression did not improve enough after trying specific antidepressants for at least 6 weeks. It may help reduce depression symptoms when standard treatments haven’t worked well.
Lund, Skåne CountyAges 25–65 - NCT05642572RecruitingPhase 2
Test drug combinations for EGFR- and MET-changed lung cancer
This Phase 2 trial tests combinations of targeted medicines to treat advanced non-small cell lung cancer (NSCLC) that has changes in both EGFR and MET genes. It is for people whose cancer continued to grow even after treatment with osimertinib, the most recent therapy.
Daphne, AlabamaAges 18 years+ - NCT05643872RecruitingPhase 3
Test gel QTORIN for adults with pachyonychia congenita
This Phase 3 study tests the safety and how the body absorbs (pharmacokinetics) of a rapamycin gel called QTORIN 3.9% in adults with pachyonychia congenita. It may help determine whether this gel is safe and works for people with this rare skin nail condition.
New Brighton, MinnesotaAges 16 years+ - NCT05644314Recruiting
Drug-coated stent for narrowed vertebral arteries
This trial studies whether a drug-coated stent placed in a narrowed vertebral artery can improve outcomes for people with artery narrowing from plaque. It also looks at how safe the stent is, since it requires specific blood-thinning medicines around the procedure.
Guangzhou, GuangdongAges 18 years+ - NCT05644457Recruiting
Testing early blood or tissue signals to track head and neck treatment
This study looks for early “biomarkers” (signals in blood or tissue) to see how well head and neck cancer treatments are working over time. It may help doctors adjust treatment sooner based on those early signals.
LondonAges 18 years+ - NCT05645510Recruiting
Study for people on long-term cancer targeted medicines
This study looks at people who are already taking long-term targeted cancer medicines. It may help researchers understand how these treatments work over time and whether there are ways to improve care.
Edmonton, AlbertaAges 18–90 - NCT05646394Recruiting
Registry for blood-clot prevention plans in arterial antiphospholipid syndrome
This study keeps a registry to follow people with antiphospholipid syndrome (APS) who have had arterial blood clots (like stroke). It collects information about the treatment approach your clinician chooses to see how different antithrombotic regimens may perform and be tolerated.
Buenos Aires, Buenos Aires F.D.Ages 18 years+ - NCT05646745Recruiting
Autologous sling surgery for stress urinary leakage in women
This trial studies a surgery that uses the patient’s own tissue to place a supportive sling for stress urinary incontinence (leakage with coughing, sneezing, or exercise). It may help women who haven’t improved with conservative treatments or who prefer not to try more non-surgical options.
CairoAges Any age - NCT05647070Recruiting
Sling surgery using your own tissue for stress urine leaks
This study looks at long-term results of a sling operation placed under the urethra using your own tissue to reduce urine leakage during activities like coughing or exercise. It may help women whose stress incontinence has not improved with conservative treatments (or who don’t want more non-surgical treatment).
CairoAges Any age - NCT05648448RecruitingPhase 2
Early flu antiviral trial for adults with confirmed influenza
This Phase 2 study compares antiviral medicines in adults who have early, flu-like symptoms and test positive for influenza. It aims to see which antiviral treatment works best and is safe for people treated soon after symptoms start.
Minas GeraisAges 18–60 - NCT05652920RecruitingPhase 1/Phase 2
CAR T-cell therapy for liver cancer that has GPC3
This early-phase study tests modified immune T cells (CAR T cells) to treat hepatocellular carcinoma (HCC), a type of liver cancer, when the tumor shows a marker called GPC3. It may help shrink tumors or slow cancer growth, especially after other treatments have stopped working.
Beijing, Beijing MunicipalityAges 18–70 - NCT05653440RecruitingPhase 2
Naming therapy training for chronic post-stroke aphasia
This Phase 2 trial studies a speech therapy approach that teaches people with aphasia how to name words, using different learning methods. You may be able to join if your language problem started after a stroke and has lasted more than 6 months.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT05653466RecruitingPhase 2
Telehealth therapy schedule for stroke-related aphasia patients
This trial tests an approach that adjusts therapy scheduling for people with long-lasting (over 6 months) language problems after a stroke. It may help some patients by matching the therapy timing to what works best for them.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT05653778Recruiting
Nerve-stimulation treatment for painful corticobasal syndrome
This trial tests “scrambler therapy,” a type of skin-based nerve stimulation, to reduce ongoing pain from corticobasal syndrome. You may be eligible if your average pain is moderate to severe and you can safely take part in the treatment schedule.
Baltimore, MarylandAges 50–89 - NCT05654753RecruitingPhase 2/Phase 3
Fecal transplant for stubborn axial spondyloarthritis
This trial tests whether transplanting healthy stool bacteria (fecal microbiota transplantation) can reduce symptoms in people with axial spondyloarthritis (including ankylosing spondylitis) who are not improving enough with standard medicines. If you qualify, you may receive study capsules containing processed bacteria and be closely monitored for safety and symptom changes.
Boulogne-BillancourtAges 18–75 - NCT05655091RecruitingPhase 2
Personalized IV antibiotics for serious Staph aureus infections
This Phase 2 study tests whether continuous IV antibiotics plus “drug level monitoring” (TDM) works better than the usual treatment for complicated Staph aureus infections. It may help ensure the antibiotic dose stays in an effective range while you’re being treated.
BaselAges 18 years+ - NCT05655195Recruiting
At-home light and sound therapy for mild Alzheimer’s
This study tests whether regular at-home “gamma” light and sound stimulation can help people with mild Alzheimer’s. Participants start with a month at home and are followed to see how they do during treatment.
Cambridge, MassachusettsAges 65–100
Common questions
- Are there clinical trials studying Treatment?
- Yes. Clin2 currently lists 8,585 recruiting studies that include Treatment, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Treatment trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Treatment an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Treatment or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.